Of note, a number of meta‐analyses advocate the use of GLP‐1RA as adjunctive therapy for patients with T1D for weight loss, insulin dose reduction, glycaemic control and enhancing metabolic profile without an increased risk of serious adverse events.117, 118, 119. The gene discussed is INS; the disease is type 1 diabetes mellitus.